SHAMETRIA TANN: Open Payments
NPI 1124615612 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,810 in 113 payments from 41 companies in 2025. Trend: 2023 $134 · 2024 $1,549 · 2025 $2,810
Food & beverage: $2,730Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $272 |
| Merck Sharp & Dohme LLC | 11 | $271 |
| TerSera Therapeutics LLC | 6 | $161 |
| PFIZER INC. | 7 | $155 |
| ABBVIE INC. | 2 | $135 |
| Lilly USA, LLC | 5 | $133 |
| Ipsen Biopharmaceuticals, Inc | 2 | $127 |
| E.R. Squibb & Sons, L.L.C. | 5 | $101 |
| Incyte Corporation | 5 | $100 |
| Pharmacosmos Therapeutics Inc. | 4 | $93 |
Products named: KEYTRUDA, RYBREVANT, VERZENIO, MONOFERRIC, TAGRISSO, Xtandi, Xermelo, OPDIVO.
Industry payments across TX — which companies pay providers there.
